Following National Advertising Division Challenge by Elanco, PetIQ Voluntarily Discontinues Certain Claims for NextStar Flea & Tick Topical
New York, NY – November 6, 2024 – Following a BBB National Programs’ National Advertising Division challenge brought by competitor Elanco Animal Health Incorporated, PetIQ, LLC discontinued the following claims for its NextStar Flea & Tick topical flea prevention and treatment product, which appeared on PetIQ’s website, social media, and third-party websites:
- “Fastest-acting 30-Day topical protection available”
- “The fastest killing flea & tick topical available”
During the proceeding, PetIQ voluntarily agreed to permanently discontinue the challenged express claims and the resulting implied claims.
Therefore, the National Advertising Division (NAD) did not review the claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended they be discontinued.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.